BRUSSELS (Reuters) - Belgian drugmaker UCB said on Thursday it had been visited by Chinese authorities as the country widens investigations into bribery by drugmakers, following allegations against GlaxoSmithKline executives.
"The Administration for Industry and Commerce has visited us," a UCB spokesman said.
(Reporting by Ben Deighton)